These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25277503)

  • 1. Strategies for modern biomarker and drug development in oncology.
    Smith AD; Roda D; Yap TA
    J Hematol Oncol; 2014 Oct; 7():70. PubMed ID: 25277503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of predictive biomarkers in oncology drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2016 Aug; 16(8):807-9. PubMed ID: 27282189
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
    El Bairi K; Atanasov AG; Amrani M; Afqir S
    Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer cell senescence: a new frontier in drug development.
    Cairney CJ; Bilsland AE; Evans TR; Roffey J; Bennett DC; Narita M; Torrance CJ; Keith WN
    Drug Discov Today; 2012 Mar; 17(5-6):269-76. PubMed ID: 22314100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive genomic biomarkers.
    Kumar R; Amado RG
    Curr Top Microbiol Immunol; 2012; 355():173-88. PubMed ID: 21877260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets in cancer therapy.
    Kummar S; Doroshow JH
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):267-9. PubMed ID: 23477512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the predictive power of preclinical models for oncology drug development.
    Honkala A; Malhotra SV; Kummar S; Junttila MR
    Nat Rev Drug Discov; 2022 Feb; 21(2):99-114. PubMed ID: 34702990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive biomarkers for cancer therapy with PARP inhibitors.
    Michels J; Vitale I; Saparbaev M; Castedo M; Kroemer G
    Oncogene; 2014 Jul; 33(30):3894-907. PubMed ID: 24037533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-biomarker co-development in oncology - 20 years and counting.
    Twomey JD; Brahme NN; Zhang B
    Drug Resist Updat; 2017 Jan; 30():48-62. PubMed ID: 28363335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges with biomarkers in cancer drug discovery and development.
    Ileana Dumbrava E; Meric-Bernstam F; Yap TA
    Expert Opin Drug Discov; 2018 Aug; 13(8):685-690. PubMed ID: 29792354
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-Agnostic Drug Development.
    Offin M; Liu D; Drilon A
    Am Soc Clin Oncol Educ Book; 2018 May; 38():184-187. PubMed ID: 30231313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of analytic methods for biomarkers used in drug development.
    Chau CH; Rixe O; McLeod H; Figg WD
    Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer biomarkers: selecting the right drug for the right patient.
    Kelloff GJ; Sigman CC
    Nat Rev Drug Discov; 2012 Feb; 11(3):201-14. PubMed ID: 22322254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome modeling and phenotypic assays for cancer precision medicine.
    Jeong E; Moon SU; Song M; Yoon S
    Arch Pharm Res; 2017 Aug; 40(8):906-914. PubMed ID: 28766239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based Design on Anticancer Drug Discovery.
    Zhong HA
    Curr Top Med Chem; 2020; 20(10):813-814. PubMed ID: 32463006
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.
    Alymani NA; Smith MD; Williams DJ; Petty RD
    Eur J Cancer; 2010 Mar; 46(5):869-79. PubMed ID: 20138504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.